Concepedia

Author

S. Falk

The Christie NHS Foundation Trust

Also Known As

S Falk, S. Falk, S.J Falk, S.J. Falk, Sally Falk

39

Publications

213

Citations

7

H-Index

16

Concepts

All Affiliations

The Christie NHS Foundation TrustUniversity of ManchesterSt James's University HospitalMount Vernon HospitalManchester Academic Health Science Centre
SF

About

S. Falk is an author at The Christie NHS Foundation Trust specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

3

3

70

2

Medicine

3

3

70

3

Pharmacology

2

2

44

4

Radiation Medicine

1

1

17

5

Cancer Epidemiology

1

1

27

S. Falk

×

5

Publications

136

Citations

5

H-Index

YearCitations

Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

Corinne Faivre‐Finn, S. Falk, Linda Ashcroft,

BMJ Open

2016

40

TOPICAL: Randomized phase III trial of erlotinib compared with placebo in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and unsuitable for first-line chemotherapy.

S. Lee, R.M. Rudd, Imran Khan,

Journal of Clinical Oncology

2010

27

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

Kate Haslett, K. Franks, Gerard G. Hanna,

BMJ Open

2016

26

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

Antonin Lévy, Lizza Hendriks, C. Le Péchoux,

Lung Cancer

2019

26

Preliminary phase II SOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC)

Rob Glynne‐Jones, David Sebag‐Montefiore, A. McDonald,

Journal of Clinical Oncology

2004

17

Page 1